Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 8, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Gastroparesis With Diabetes Mellitus
Interventions
DEVICE

transcutaneous electrical accustimulation at treatment point.

The transcutaneous electrical accustimulator (TEA) device administers a mild electrical shock through the skin, similar to acupuncture at a location previously seen to provide benefit. The precise distinction between sham and experimental accustimulation is not described upon registration to reduce unblinding risk, to maintain scientific integrity.

DEVICE

transcutaneous electrical accustimulation at sham point.

The transcutaneous electrical accustimulator (TEA) device administers a mild electrical shock through the skin, similar to acupuncture at a location which has not been shown to provide benefit. The precise distinction between sham and experimental accustimulation is not described upon registration to reduce unblinding risk, to maintain scientific integrity.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Michigan

OTHER